The agency is aware of more than 14,000 substances on the EU market with some indication of skin-sensitization concern. Using the OECD guideline, adopted in June, registrants may be able to make conclusive predictions without use of animals and should update REACH dossiers accordingly.
The European Chemicals Agency affirms that skin sensitization – a chemical safety endpoint that historically could not be assessed without animal testing – can be predicted using specific combinations of in silico, in chemico, and in vitro data.
“This is an important milestone for advancing the use of alternative methods to assess chemical hazards. With the new guideline,...
Create an account to read this article
Already a subscriber?
Young people are even more enthusiastically adopting artificial intelligence, notes consulting firm Simon-Kucher in its latest Better Health Report, with 81% of 18-to-28-year-olds reporting that AI has a role to play in their health-related decision making.
“The European Commission’s work on harmonizing maximum levels of vitamins and minerals should fully reflect the positive role that food supplements can play in safely and effectively addressing micronutrient gaps,” insists Food Supplements Europe chair Peter Loosen.
HBW Insight speaks to AESGP's governmental and public affairs manager, Luis Rhodes Baiao, about the association's Self-Care Insight and Inspire platform, which brings together inspiring self-care initiatives from across Europe.
The NHS App should direct users to trusted, external OTC brand resources where appropriate, says PAGB in its latest report.
Tmall’s business development manager, Aline Hu, and founder of cross-border e-commerce specialist QIVA Global, Ellie Adams, offer advice to multinational consumer healthcare players looking to enter the potentially lucrative and growing Chinese consumer healthcare import market.
Cemag Care may be behind the recent Rx-to-OTC switch of menstrual health treatment tranexamic acid (1000mg) in France.
Haleon's Asia-Pacific president Keith Choi reveals how the firm is intending to grow its China business in a challenging but potentially extremely lucrative consumer health market.
